Encompass Health Corporation (EHC) Tops Q4 EPS by 5c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlook Above Consensus

Note: EPS may not be comparable

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1 billion versus the consensus estimate of $999.77 million.

GUIDANCE:

Encompass Health Corporation sees FY2018 EPS of $3.25-$3.40, versus the consensus of $3.27. Encompass Health Corporation sees FY2018 revenue of $4.15-4.25 billion, versus the consensus of $4.16 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• Hermès can regain momentum despite China weakness, Jefferies says